Attapon Cheepsattayakorn^1,2,3,4*, Ruangrong Cheepsattayakorn⁵ and Porntep Siriwanarangsun¹

¹Faculty of Medicine, Western University, Pathumtani Province, Thailand
²Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
³10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
⁴Department of Disease Control, Ministry of Public Health, Thailand
⁵Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.

Received: December 02, 2024; Published: January 01, 2025

Abstract

Pneumonia, the second most prevalent nosocomial infection among patients in critical care, affects almost 27% of all critically ill patients [1]. Linkage to mechanical ventilation is found around 86% of nosocomial pneumonia patients and are referred to as ventilator-associated pneumonia (VAP) [1]. Due to instrumentation of the airway during mechanical ventilation, which lasts for >48 h, the oropharynx and trachea structures may Received: December 02, 2024 Published: January 01, 2025 © All rights are reserved by Attapon Cheepsattayak., et al. There is limitation and restriction of the VAP-antimicrobial optimal-duration therapy with a few clinical-trial findings in current be affected. Secretions and flora from upper respiratory tract can infiltrate the lower respiratory system causing VAP by affecting the lung parenchyma

References

1. G Dimopoulos., et al. “Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia”. Chest (2013).
2. M Fekih Hassen., et al. “Durée de l’antibiothérapie lors du traitement des pneumopathies acquises sous ventilation mécanique : comparaison entre sept jours et dix jours. Étude pilote”. Annales Françaises d'Anesthésie et de Réanimation (2009).
3. MJ Richards., et al. “Nosocomial infections in medical intensive care units in the United States”. Critical Care Medicine (1999).
4. S Amanullah., et al. “What are ventilator-associated pneumonias/ventilator-associated events and how to reduce their prevalence in your hospital”. Medscape (2015).
5. SM Koenig., et al. “Ventilator-associated pneumonia: diagnosis, treatment, and prevention”. Clinical Microbiology Review (2006).
6. L Papazian., et al. “Effect of ventilator-associated pneumonia on mortality and morbidity”. American Journal of Respiratory and Critical Care Medicine (1996).
7. Mo Y., et al. “Individualized, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicenter, individually randomized, open-label, non-inferiority trial”. Lancet Respiratory Medicine5 (2024): 399-408.
8. JF Timsit., et al. “Attributable mortality of ventilator-associated pneumonia”. Current Opinion in Critical Care (2011).
9. J Steen., et al. “Attributable mortality of ventilator-associated pneumonia. Replicating findings, revisiting methods”. Annals of the American Thoracic Society (2020).
10. AC Kalil., et al. “Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society”. Clinical Infectious Disease (2016).
11. A Torres., et al. “International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia”. European Respiratory Journal (2017).
12. R Pugh., et al. “Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults”. Cochrane Database System Review (2015).
13. Mo YinMo Yin., et al. “Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial”. The Lancet Respiratory Medicine5 (2022): 399-408.
14. Hornick I. “Individualized short antibiotic course non-inferior to usual course in VAP”. Post online : February 5, (2024).

Citation

Citation: Attapon Cheepsattayakorn., et al. “Pneumonia Patients Associated with Ventilator with Short-Course Antimicrobial Treatment". Acta Scientific Microbiology 8.2 (2025): 01-03.

Copyright

Copyright: © 2025 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.